TELTUXA Trademark

Trademark Overview

On Thursday, August 29, 2019, a trademark application was filed for TELTUXA with the United States Patent and Trademark Office. The USPTO has given the TELTUXA trademark a serial number of 88597823. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 22, 2023. This trademark is owned by AbbVie Inc.. The TELTUXA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
teltuxa

General Information

Serial Number88597823
Word MarkTELTUXA
Filing DateThursday, August 29, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 22, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 12, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbVie Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064
Party NameAbbVie Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Chicago, IL 60064

Trademark Events

Event DateEvent Description
Monday, May 22, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 22, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, October 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 13, 2022SOU EXTENSION 5 GRANTED
Wednesday, October 5, 2022SOU EXTENSION 5 FILED
Thursday, October 13, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 5, 2022TEAS EXTENSION RECEIVED
Friday, March 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 23, 2022SOU EXTENSION 4 GRANTED
Wednesday, March 23, 2022SOU EXTENSION 4 FILED
Wednesday, March 23, 2022TEAS EXTENSION RECEIVED
Thursday, October 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 19, 2021SOU EXTENSION 3 GRANTED
Tuesday, October 19, 2021SOU EXTENSION 3 FILED
Tuesday, October 19, 2021TEAS EXTENSION RECEIVED
Friday, April 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 21, 2021SOU EXTENSION 2 GRANTED
Wednesday, April 21, 2021SOU EXTENSION 2 FILED
Wednesday, April 21, 2021TEAS EXTENSION RECEIVED
Friday, October 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 14, 2020SOU EXTENSION 1 GRANTED
Wednesday, October 14, 2020SOU EXTENSION 1 FILED
Wednesday, October 14, 2020TEAS EXTENSION RECEIVED
Tuesday, April 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 25, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 5, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 22, 2019ASSIGNED TO EXAMINER
Tuesday, September 17, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2019NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2019NON-FINAL ACTION WRITTEN
Sunday, September 15, 2019ASSIGNED TO EXAMINER
Thursday, September 12, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 2, 2019NEW APPLICATION ENTERED

Related Keywords

teltuxa gastrointestinal hormonal neurological respiratory ophthalmic dermatological psychiatric diseases disorders related